跳至主要内容
临床试验/NCT05439369
NCT05439369Unknown不适用

Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease

Assiut University1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2022年8月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
early detection of subclinical LV dysfunction.

研究概览

简要总结

NPs can be used To detect subset of asymptomatic with subtle LV dysfunction for further evaluation and earlier referral for intervention and its correlation with echocardiographic finding.

详细描述

Each patient included in the study will undergo:

  1. History taking:

Analysis of patient symptoms and signs (dyspnea , orthopnea , Paroxysmal nocturnal dyspnea, lower limb edema , tachypalpitations,...etc ) 2. Clinical examination:

  • Detecion of each patient body weight , height , calculation of BMI.
  • General examination for detection of signs of Heart failure (raised JVP , lower limb edema, ..etc)
  • Examination to respiratory system
  • Auscultation of the heart for detection of valvular affection before echocardiography

Invesigations:

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients echocardiographically diagnosed with significant valve lesions. Rheumatic Heart disease with significant but asymptomatic valvular Heart Disease especially (Mitral valve disease )(MS and MR) Gender: male & female

排除标准

  • Cases with increased level of BNP as in :
  • Renal impairment Advanced age and obesity Atrial fibrillation and acute coronary syndromes Prior lung diseases and acute illness

结局指标

主要结局

early detection of subclinical LV dysfunction.

时间窗: 1 year

early detection of subclinical LV dysfunction.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Muhammad Khidr Ezzat thabet

Resident Doctor

Assiut University

研究点 (1)

Loading locations...

相似试验